AMBER LITTLEFIELD: Open Payments
NPI 1538440094 · BROUSSARD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$93,703 in 332 payments from 16 companies in 2025. Trend: 2023 $43,167 · 2024 $82,283 · 2025 $93,703
Honoraria: $65,167Speaker / faculty: $16,500Travel & lodging: $6,894Food & beverage: $5,143
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 158 | $74,350 |
| ABBVIE INC. | 66 | $17,472 |
| Otsuka America Pharmaceutical, Inc. | 23 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $347 |
| Tris Pharma Inc | 11 | $214 |
| Corium, LLC | 12 | $181 |
| Noven Therapeutics, LLC | 8 | $142 |
| Vanda Pharmaceuticals Inc. | 7 | $139 |
| Alkermes, Inc. | 12 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
Products named: Auvelity, VRAYLAR, REXULTI, CAPLYTA, Dyanavel XR, Azstarys, Xelstrym, FANAPT.
Industry payments across LA — which companies pay providers there.
